Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

The Longevity Formula

The Longevity Formula artwork

The Fire in the Brain: How Inflammation is Driving Parkinson’s, Alzheimer’s & Long COVID | Cuong Do

May 23, 202541 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Is chronic neuroinflammation the silent driver behind modern brain diseases like Parkinson's, Alzheimer's, Long COVID, and mood disorders? In this eye-opening episode, Dr. Brandon Crawford speaks with Cuong Do, the CEO of BioVie Pharmaceuticals, who came out of retirement to tackle the growing challenge of neurodegenerative diseases. They delve into the intricate science of TNF-alpha, explore the concept of insulin resistance within the brain, and discuss the potential of next-generation neurodrugs, such as BioVie's Bezisterem, to not only alleviate symptoms but potentially alter the trajectory of aging itself. Join them as they unpack the significance of ongoing clinical trials, the implications of biological clocks and mitochondrial health, and the often-overlooked connections between inflammation and crucial aspects of health, including cognition, hormones, longevity, and even autism. Key Takeaways Many chronic conditions, including neurodevelopmental disorders and autoimmune diseases, may stem from fundamental light signaling failures at the cellular level. In Alzheimer's disease, TNF-alpha drives the production of amyloid precursor protein (APP) and the phosphorylation of tau, contributing to amyloid plaques and tau tangles, though these may be downstream effects of inflammation. Emerging research links the brain fog, fatigue, and malaise associated with Long COVID to inflammatory mechanisms that BioVie’s drug candidate, Bezisterem, aims to modulate. Pre-clinical studies of Bezisterem in Parkinson's models showed it to be as effective as Levodopa in restoring muscle control and demonstrated a synergistic effect when used in combination. Bezisterem is a small molecule that readily crosses the blood-brain barrier and has shown a long half-life, potentially offering benefits for Parkinson's patients experiencing "off" states in the morning. BioVie is actively monitoring biomarkers of neurodegeneration, such as GFAP and neurofilament light (NFL), in their clinical trials and has observed a disruption in the typical correlation between disease progression and these markers in the treatment arm. Resources BioVie Pharmaceuticals: biovpharma.com Clinical Trials Info: https://www.bioviepharma.com/clinical-trials Products: Lasers & Stimpods 528i Clinical Mastery Course NeuroSolution Supplements STEMREGEN® For more information, resources, and podcast episodes, visit tinyurl.com/3ppwdfpm

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Hosts

  • Dr. Brandon Crawford Host Feed-stated

Guests

  • Cuong Do Guest Feed-stated

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Why You’re Tired All Day & Wide Awake at Night | Dr. Patrick Porter

    Oct 23, 202658 minAudio

    Your brain can run on stress all day and still not know how to power down.Stress isn’t the enemy. Stress without recovery is. When the brain never shifts out of high alert, energy crashes by afternoon and sleep slips...

    Credit the people on this episode

  2. The Microdosing Secret Reshaping Weight Loss, Muscle & the Brain’s Reward System | Jay Campbell

    Oct 9, 202657 minAudio

    Tens of millions of people are injecting GLP-1s right now, and Jay Campbell argues most of them are on the wrong dose. Standard titration, he says, leaves people sick, shedding muscle, and sometimes losing the drive...

    Credit the people on this episode

  3. Why Your Peptide Isn’t Working: The Foundation Every Protocol Skips | Dr. Greg Jones

    Sep 18, 202652 minAudio

    Most peptide protocols aren't failing because the peptide is wrong. They're failing because nobody fixed the foundation underneath it, the inflammation, poor sleep, and oxidative stress that drown out the signal before...

    Credit the people on this episode

  4. The Hit-and-Run That Should Have Killed Him: A Teen Cyclist's Biologically Impossible Survival | Walker Carroll

    Sep 4, 202643 minAudio

    Walker Carroll was sixteen, a state champion cyclist with a clear path to racing professionally, when a single training ride changed everything. On February 6, 2026, a truck hit him from behind at more than seventy...

    Credit the people on this episode

  5. The Ancient Longevity Science That Modern Medicine Ignores | Dr. John Douillard

    Aug 21, 202653 minAudio

    Dr. John Douillard has spent more than 40 years proving ancient medicine with modern science. A chiropractor, Certified Ayurvedic Practitioner, bestselling author, and former Director of Player Development for the NBA's...

    Credit the people on this episode